This special summer issue serves as an “expression platform” for as many different industry voices as we could squeeze in between our front and back covers. To get even more points of view than our ...

BPI is poised to enter its 23rd year in print. The 21st century has brought many changes to publishing(e.g., from online presence as a “value-add” to an essential) but throughout the decades, some ...

We at BPI had so much fun putting together our big anniversary retrospective issue last year that we decided to make it an annual tradition starting this year — albeit on a bit smaller scale. There’s ...

May 2022 Featured ReportA number of factors contribute to delivering a robust, highly productive, and reliable process for manufacturing a therapeutic protein. They begin with a cell-host system and a ...

Early decisions can impact the success of a novel gene therapy, so how can therapeutics companies make sure to set off on the right track? In this article, drug developers will learn some things that ...

Explore the latest news and expert commentary on From the Editor, brought to you by the editors of BioProcess International ...

When I was supposed to be writing this editorial, I instead was watching the funeral of former US president James Earl Carter of Georgia. The eulogy and speeches by family members and politicians were ...

Consistent, high-quality purification is essential to delivering safe and effective biotherapeutics, and chromatography plays a central role in making that happen. But even the best resins can fall ...

Explore the latest news and expert commentary on Biochemicals/Raw Materials, brought to you by the editors of BioProcess International ...

Explore the latest news and expert commentary on Cell Culture Media, brought to you by the editors of BioProcess International ...

Explore the latest news and expert commentary on Upstream & Downstream Processing, brought to you by the editors of BioProcess International ...

BPI's March 2025 Featured Report highlights advances in vaccine development, with cancer vaccines receiving particular attention.